Boundless Bio, Inc. (BOLD) vs Fractyl Health, Inc. (GUTS)

Boundless Bio, Inc. and Fractyl Health, Inc. are both Biotechnology companies. Boundless Bio, Inc. and Fractyl Health, Inc. are of similar size ($55.2M and $53.5M). Across the 8 metrics below, Fractyl Health, Inc. leads on 5 and Boundless Bio, Inc. on 3.

Valuation

Metric BOLD GUTS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 2,644.15 9.71
P/B 0.80 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2,464.64 9.21
Earnings yield (122.22%) (56.77%) (33.15%)
Free cash flow yield (107.99%) (33.75%) (25.50%)

Profitability

Metric BOLD GUTS Biotechnology median
Gross margin — 46.24% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (67.86%) 1,063.04% (56.36%)
Return on assets (50.56%) (146.75%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BOLD GUTS Biotechnology median
Revenue growth (TTM) — (22.50%) 6.02%
EPS growth (last fiscal year) 32.47% (14.81%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric BOLD GUTS Biotechnology median
Debt to equity 0.00 (18.29) 0.00
Current ratio 9.48 3.15 4.72
Net debt to EBITDA 0.99 0.53 0.96

Dividend

Metric BOLD GUTS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BOLD GUTS Biotechnology median
Market cap 53.46m 55.18m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack